Fact: According to the U.S. Food and Drug Administration, African-Americans make up about 5 percent of clinical trial participants and Latino Americans constitute 1 percent.African-Americans are diagnosed with more advanced cancer, and death rates are higher. One way to help combat the issue is to have more people of color participate in clinical trials. But overcoming historical stigma is a major concern for minority populations and is likely one of the most common factors driving the low participation numbers.
Help a Friend
Search the Site
-
Latest Posts
- New Insights Into Prevention and Management of Chronic Pain in Children and Adolescents | NCCIH May 29, 2023
- Juneteenth 2023: 19 Days of Wellness Tickets | Eventbrite May 26, 2023
- Brain signatures for chronic pain identified in a small group of individuals | National Institutes of Health (NIH) May 23, 2023
- 5 Mistakes We Make When We’re Overwhelmed May 21, 2023
- In Court-Ordered Family Reunification Camps, Kids Allege More Abuse — ProPublica May 19, 2023
New Comments